首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1746496

日本骨科生物製品市場報告（按產品、類型、應用、最終用戶和地區）2025 年至 2033 年

Japan Orthobiologics Market Report by Product, Type, Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本骨科生物製劑市場規模達2.835億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到5.082億美元，2025-2033年期間的複合年成長率（CAGR）為6.2%。日益成長的老齡化人口是推動市場發展的主要因素。由於久坐不動的生活方式和肥胖等因素，老齡化人口更容易患骨關節炎和骨折等骨科疾病。

骨科生物製劑是醫學的一個領域，專注於利用天然物質和生物材料來增強人體自身的癒合過程，特別是在骨科和肌肉骨骼疾病領域。這些療法旨在刺激組織修復和再生，減少對更具侵入性的外科手術的需求，並可能改善患者的預後。常見的骨科生物製劑包括富血小板血漿 (PRP)，該療法透過濃縮並注射患者自身的血小板來促進組織癒合；以及幹細胞療法，該療法利用患者自身或捐贈者的幹細胞來促進組織再生。此外，還有一些產品，例如骨移植和合成材料，可以模擬天然骨骼的特性，以支持骨折癒合和脊椎融合。骨科生物製劑代表了骨科領域一個充滿希望的研究和治療領域，它有可能加速各種肌肉骨骼疾病（例如關節炎、肌腱損傷和骨折）患者的康復、減輕疼痛並改善整體功能。

日本骨科生物製劑市場趨勢：

日本的骨科生物製品市場正經歷強勁成長，這主要得益於一系列因素，這些因素凸顯了其光明的前景。首先，人口老化極大地促進了市場的擴張。隨著年齡的成長，骨關節炎和骨折等肌肉骨骼疾病的發生率不斷上升，因此需要透過骨科生物製品治療來促進組織再生和修復。因此，老年人口的成長是市場成長的重要驅動力。此外，技術進步在推動骨科生物製品市場發展方面發揮了關鍵作用。生物技術和再生醫學的創新促進了更先進、更有效的骨科生物製品產品的開發。這包括幹細胞療法、富血小板血漿 (PRP) 療法和基於生長因子的解決方案的出現，所有這些療法都能改善患者的治療效果，從而推動對這些尖端療法的需求。此外，新興的微創手術應用可提供更快的恢復時間、更少的疼痛和更少的併發症，預計將在預測期內推動日本骨科生物學市場的發展。

日本骨科生物學市場細分：

產品洞察：

去礦骨基質
同種異體移植
骨形態發生蛋白
黏液補充產品
合成骨替代品
其他

類型洞察：

膝蓋
踝
時髦的
腕部和肩部
脊椎
其他

應用程式洞察：

骨關節炎和退化性關節炎
脊椎融合
骨折恢復
軟組織損傷
顎面和牙科應用

最終用戶洞察：

醫院及門診中心
研究與學術機構
牙科診所和設施
骨科診所

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本骨科生物製劑市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本骨科生物製劑市場有何影響？
日本骨科生物製劑市場依產品分類是怎樣的？
日本骨科生物製劑市場按類型分類是怎樣的？
日本骨科生物製劑市場根據應用如何分類？
根據最終用戶，日本骨科生物製劑市場是如何分類的？
日本骨生物學市場的價值鏈分為哪些階段？
日本骨生物學領域的主要促進因素和挑戰是什麼？
日本骨生物學市場的結構是怎麼樣的？主要參與者是誰？
日本骨生物製劑市場的競爭程度如何？

本報告回答的關鍵問題：

日本骨科生物製劑市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本骨科生物製劑市場有何影響？
日本骨科生物製劑市場依產品分類是怎樣的？
日本骨科生物製劑市場按類型分類是怎樣的？
日本骨科生物製劑市場根據應用如何分類？
根據最終用戶，日本骨科生物製劑市場是如何分類的？
日本骨生物學市場的價值鏈分為哪些階段？
日本骨生物學領域的主要促進因素和挑戰是什麼？
日本骨生物學市場的結構是怎麼樣的？主要參與者是誰？
日本骨生物製劑市場的競爭程度如何？

Japan orthobiologics market size reached USD 283.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 508.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The growing aging population, who are prone to orthopedic conditions such as osteoarthritis and fracture, on account of several factors, like sedentary lifestyles and obesity, is primarily driving the market.

Orthobiologics is a field of medicine that focuses on using natural substances and biological materials to enhance the body's own healing processes, particularly in orthopedic and musculoskeletal conditions. These therapies aim to stimulate tissue repair and regeneration, reducing the need for more invasive surgical interventions and potentially improving patient outcomes. Common orthobiologics include platelet-rich plasma (PRP), which involves concentrating and injecting a patient's own platelets to promote tissue healing, and stem cell therapy, which utilizes a patient's own stem cells or those from a donor to encourage tissue regeneration. Additionally, there are products like bone grafts and synthetic materials that mimic the properties of natural bone to support fracture healing and spinal fusion. Orthobiologics represent a promising area of research and treatment in orthopedics, with the potential to accelerate recovery, reduce pain, and improve overall function in patients with various musculoskeletal conditions, such as arthritis, tendon injuries, and bone fractures.

Japan Orthobiologics Market Trends:

The orthobiologics market in Japan is experiencing robust growth, primarily driven by a confluence of factors that underscore its promising future. Firstly, an aging population has significantly contributed to the market's expansion. As individuals age, the incidence of musculoskeletal disorders such as osteoarthritis and fractures increases, necessitating orthobiologic treatments that facilitate tissue regeneration and repair. Consequently, the rising geriatric demographic acts as a substantial driving force for the market's growth. Furthermore, technological advancements have played a pivotal role in propelling the orthobiologics market forward. Innovations in biotechnology and regenerative medicine have led to the development of more sophisticated and effective orthobiologic products. This includes the emergence of stem cell therapies, platelet-rich plasma (PRP) treatments, and growth factor-based solutions, all of which offer improved patient outcomes, driving demand for these cutting-edge therapies. Additionally, the emerging application of minimally invasive procedures that offer quicker recovery times, reduced pain, and fewer complications is expected to drive the orthobiologics market in Japan during the forecast period.

Japan Orthobiologics Market Segmentation:

Product Insights:

Demineralized Bone Matrix
Allograft
Bone Morphogenetic Protein
Viscosupplementation Products
Synthetic Bone Substitutes
Others

Type Insights:

Knee
Ankle
Hip
Wrist and Shoulder
Spine
Others

Application Insights:

Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications

End User Insights:

Hospitals and Ambulatory Centers
Research and Academic Institutes
Dental Clinics and Facilities
Orthopedic Clinics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan orthobiologics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan orthobiologics market?
What is the breakup of the Japan orthobiologics market on the basis of product?
What is the breakup of the Japan orthobiologics market on the basis of type?
What is the breakup of the Japan orthobiologics market on the basis of application?
What is the breakup of the Japan orthobiologics market on the basis of end user?
What are the various stages in the value chain of the Japan orthobiologics market?
What are the key driving factors and challenges in the Japan orthobiologics?
What is the structure of the Japan orthobiologics market and who are the key players?
What is the degree of competition in the Japan orthobiologics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Orthobiologics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Orthobiologics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Orthobiologics Market - Breakup by Product

6.1 Demineralized Bone Matrix
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Allograft
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Bone Morphogenetic Protein
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Viscosupplementation Products
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Synthetic Bone Substitutes
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 Others
- 6.6.1 Historical and Current Market Trends (2019-2024)
- 6.6.2 Market Forecast (2025-2033)

7 Japan Orthobiologics Market - Breakup by Type

7.1 Knee
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Ankle
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Hip
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Wrist and Shoulder
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Spine
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Orthobiologics Market - Breakup by Application

8.1 Osteoarthritis and Degenerative Arthritis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Spinal Fusion
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Fracture Recovery
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Soft Tissue Injuries
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Maxillofacial and Dental Applications
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)

9 Japan Orthobiologics Market - Breakup by End User

9.1 Hospitals and Ambulatory Centers
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Research and Academic Institutes
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Dental Clinics and Facilities
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Orthopedic Clinics
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)

10 Japan Orthobiologics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Orthobiologics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis